Weight loss injections, particularly GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro), have raised questions about potential cancer risks
In a clinical study, these highly effective weight loss injections helped men and women lose an average of 9-13 percent of their body weight over a year without making changes to their diet or exercise habits
Related Reading Compounded Glp 3 Alternatives For Ozempic Ozempic Alternatives Glp 1 Alternatives Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
'If you give us five minutes to go do something really fast,' Kourtney hints at her sister through grinning teeth before leaving the room with her rockstar husband
The short answer is that there is no absolute contraindication that prevents these two medications from being used together
Scaling up production for advanced biologics like ADCs and RNAi therapies is another challenge